Allworth Financial’s Opus Genetics IRD Stock Holding History

Allworth Financial’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23	Hold	5	–	–	﹤0.01%	5124
2025 Q4	$11	Buy	+5	New	+$10	﹤0.01%	4949

Other funds holding IRD

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Allworth Financial's IRD Position: Q1 2026 in Review

Allworth Financial held its Opus Genetics (IRD) position steady in Q1 2026 at 5 shares worth $23. The position accounts for ﹤0.01% of the portfolio, ranked #5124.

Allworth Financial first reported a position in IRD in Q4 2025 and has held it in 2 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

Allworth Financial held 5 shares of Opus Genetics worth $23 as of Q1 2026.
Allworth Financial left its Opus Genetics share count unchanged in Q1 2026.
Opus Genetics made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #5124 holding.
Allworth Financial first reported a position in Opus Genetics in Q4 2025 and has held it in 2 quarters since.
79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.